Intracept Minimally-invasive PROcedure for VErtebrogenic Back Pain
Status: Recruiting
Location: See all (10) locations...
Intervention Type: Device
Study Type: Observational
SUMMARY
Compile real-world outcomes of commercially approved Intracept™ Intraosseous Nerve Ablation Systems in the treatment of patients diagnosed with vertebrogenic pain.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
View:
• Study candidate is scheduled to be treated with a commercially approved Intracept™ Intraosseous Nerve Ablation System per local Instructions for Use (IFU).
• Signed a valid, IRB/EC-approved informed consent form.
Locations
United States
Arizona
Flagstaff Bone & Joint
RECRUITING
Flagstaff
California
MarinHealth Spine Institute
RECRUITING
Larkspur
Connecticut
The Spine Wellness Center in Westport
RECRUITING
Westport
Washington, D.c.
Washington Hospital Center
RECRUITING
Washington D.c.
Idaho
North Idaho Day Surgery, LLC
RECRUITING
Post Falls
Louisiana
Ochsner Clinic Foundation
RECRUITING
New Orleans
Minnesota
iSpine Clinics
RECRUITING
Maple Grove
New York
University of Rochester
RECRUITING
Rochester
Oregon
Pacific Sports and Spine
RECRUITING
Eugene
Utah
University of Utah Orthopaedic Center
RECRUITING
Salt Lake City
Contact Information
Primary
Ann Yamano
BSNClinicalTrials@bsci.com
855-213-9890
Backup
Diane Keesey
BSNClinicalTrials@bsci.com
855-213-9890
Time Frame
Start Date: 2025-03-26
Estimated Completion Date: 2034-07
Participants
Target number of participants: 1500
Treatments
Intracept™ Intraosseous Nerve Ablation Systems
Subjects with pain treated with a commercially approved Intracept™ Intraosseous Nerve Ablation System
Related Therapeutic Areas
Sponsors
Leads: Boston Scientific Corporation